Novavax Inc
Change company Symbol lookup
Select an option...
NVAX Novavax Inc
MRK Merck & Co Inc
HYT BlackRock Corporate High Yield Fund, Inc
FNMA Federal National Mortgage Association
CPKF Chesapeake Financial Shares Inc
AGNC Agnc Investment Corp
BYND Beyond Meat Inc
NDENF Central African Gold Inc
HD Home Depot Inc
ACPS AC Partners Inc

Health Care : Biotechnology | Mid Cap Value
Company profile

Novavax, Inc. is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company, through its recombinant nanoparticle vaccine technology, produces vaccine candidates to respond to both known and newly emerging diseases. The Company's product pipeline focuses on a range of infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus (RSV), seasonal influenza, pandemic influenza and the Ebola virus (EBOV). The Company's lead adjuvant for human applications, Matrix-M, is in a Phase I/II clinical trial for pandemic influenza H7N9 vaccine candidate. It is also testing Matrix-M in conjunction with its EBOV vaccine candidate in a Phase I clinical trial. It is developing additional pre-clinical stage programs in a range of infectious diseases, including Middle East respiratory syndrome (MERS).

Closing Price
Day's Change
-4.99 (-4.66%)
B/A Size
Day's High
Day's Low

10-day average volume:

UPDATE: With a potential selloff looming, investors need to rethink their approach to Big Tech, Barclays strategist warns

2:19 pm ET October 10, 2020 (MarketWatch)

Shawn Langlois

Don't let your portfolio get sucked into that ever smaller batch of recent winners, analyst warns

That's Barclays Wealth Chief Investment Officer, Will Hobbs, warning in an interview on CNBC ( published on Wednesday of a potential selloff in big technology company stocks such as Amazon (AMZN) , Apple (AAPL) , Alphabet (GOOGL) , Netflix (NFLX) , Tesla (TSLA) , Microsoft (MSFT) etc., in the face of rising interest rates.

"One of the theories around the current context for markets is that a lot of it is quite dependent on ever-lower real interest rates, because if you think about the valuation of some of these tech titans, think about the shape of their cash flows, they're sort of like long-duration bonds," Hobbs said.

He explained that these big tech winners have been the beneficiary of falling interest rates for years now, but he warned that it won't last forever, particularly in light of the world's unprecedented policy environment. "The industry has long been obsessed, and investors are understandably obsessed with the idea that you can protect downside and capture equity upside," Hobbs said. "That is like the Holy Grail of investing."

He added that a shake-up is in order for investors leaning too heavily on the tech companies driving the bull market. "You have to own some losers as well, because you have to plan for a future that isn't just a continuation of the recent past, as so often isn't the case," Hobbs said.

His comments were published in the wake of a U.S. House subcommittee report (, which concluded this week that Big Tech dominance poses a grave threat to market that might require breaking up top U.S. tech companies. "To put it simply, companies that once were scrappy, underdog startups that challenged the status quo have become the kinds of monopolies we last saw in the era of oil barons and railroad tycoons," Rep. David Cicilline, D-R.I., chairman of the House Judiciary Antitrust, Commercial and Administrative Law Subcommittee, said in a statement.

As for Wednesday's bounceback trading session, no signs of a selloff just yet, with the Dow Jones Industrial Average , tech-heavy Nasdaq Composite and S&P 500 all logging strong gains.

-Shawn Langlois; 415-439-6400;

(END) Dow Jones Newswires

October 10, 2020 14:19 ET (18:19 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.